Back to discover
Disease
Hyperthyroidism
Late-stage therapeutic developmentEmerging research
3
Publications
9
Clinical trials
1
Related conditions
2024
Latest publication
Latest activity
betaRecent clinical, regulatory, research and industry developments relating to this disease.
Research2024-08-19Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme
Effects of thyroid hormones in skeletal muscle protein turnover.
Research2024-07-01Journal of basic and clinical physiology and pharmacology
Research2016-10-01Thyroid : official journal of the American Thyroid Association
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Executive briefingUpdating summary…Momentum: Low
Key developments
- 2 clinical trials expected to report results, the earliest in Q1 2027.
Major developments
Upcoming trial readoutImportant
Results expected Q3 20282026-02-10
Upcoming trial readoutImportant
Results expected Q1 20272026-01-27
Clinical MilestonesViewHide
Results expected
- 2026-02-10Preoperative Lugol's Solution in Graves' Disease and Toxic Nodular GoiterResults expected Q3 2028
- 2026-01-27Impact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease: A Pilot Feasibility TrialResults expected Q1 2027
Activity timeline2
- 2026-02-10ClinicalPreoperative Lugol's Solution in Graves' Disease and Toxic Nodular GoiterResults expected Q3 2028
- 2026-01-27ClinicalImpact of Vitamin D Therapy on Thyroid Function and Antibody Levels in Pediatric Graves' Disease: A Pilot Feasibility TrialResults expected Q1 2027
Clinical trials
The current development programme across all trial phases.
Clinical programme
9
2
7
6
Late-stage studies
Recruiting
Recently completed
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Publications over time
20162024
Most influential
Recent publications
Major themes8
- Thyroid Hormones2
- Diabetes Mellitus, Type 21
- Evidence-Based Medicine1
- Hyperthyroidism1
- Muscle Proteins1
- Muscle, Skeletal1
- Muscular Atrophy1
- Precision Medicine1
Leading journals3
- Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme1
- Journal of basic and clinical physiology and pharmacology1
- Thyroid : official journal of the American Thyroid Association1
Leading researchers8
- Burch HB1
- Chauhan A1
- Cooper DS1
- Crocetto F1
- Fusco F1
- Greenlee MC1
- Laurberg P1
- Maia AL1
Affiliations (unnormalised)6
- 1 Massachusetts General Hospital1
- 11 Institute of Nuclear Medicine1
- 5 Departments of Clinical Medicine and Endocrinology1
- Department of Clinical Medicine and Surgery1
- Diabetes and Clinical Nutrition1
- Duke University School of Medicine1
Related conditions
Diseases frequently studied alongside this one. Number shows shared papers.
Reference
Authoritative identity, definition & identifiers.
Defined in MeSH
Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE.
Identifiers
References & data sources
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.